121 related articles for article (PubMed ID: 17671528)
21. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
22. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
[TBL] [Abstract][Full Text] [Related]
23. [HPV detection and FHIT expression in esophageal squamous carcinoma from high incidence area in Cixian County].
Liu YL; Li XM; Jin GL; Yan X; Yang JZ; Wang JL; Li YH; Wang FR; Zhang XH
Ai Zheng; 2003 May; 22(5):492-5. PubMed ID: 12753709
[TBL] [Abstract][Full Text] [Related]
24. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of hMLH1 and hMSH2 proteins in vulvar carcinoma.
Kwasniewska A; Postawski K; Gozdzicka-Józefiak A; Zdunek M; Korobowicz E; Miturski R
Int J Mol Med; 2005 Jun; 15(6):955-61. PubMed ID: 15870899
[TBL] [Abstract][Full Text] [Related]
26. Higher incidence of p53 mutation in cervical carcinomas with intermediate-risk HPV infection.
Kim HJ; Song ES; Hwang TS
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):213-8. PubMed ID: 11574134
[TBL] [Abstract][Full Text] [Related]
27. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.
Wu R; Connolly DC; Dunn RL; Cho KR
J Natl Cancer Inst; 2000 Feb; 92(4):338-44. PubMed ID: 10675384
[TBL] [Abstract][Full Text] [Related]
28. Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated cervical cancer in Indian women.
Neyaz MK; Hussain S; Hassan MI; Das BC; Husain SA; Bharadwaj M
Mol Cell Biochem; 2010 Feb; 335(1-2):53-8. PubMed ID: 19730990
[TBL] [Abstract][Full Text] [Related]
29. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.
Shin KH; Park KH; Hong HJ; Kim JM; Oh JE; Choung PH; Min BM
Int J Oncol; 2002 Aug; 21(2):297-302. PubMed ID: 12118324
[TBL] [Abstract][Full Text] [Related]
31. Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.
Helland A; Kraggerud SM; Kristensen GB; Holm R; Abeler VM; Huebner K; Borresen-Dale AL; Lothe RA
Int J Cancer; 2000 Oct; 88(2):217-22. PubMed ID: 11004671
[TBL] [Abstract][Full Text] [Related]
32. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
33. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
34. Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men.
Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T
Pathol Int; 2008 Aug; 58(8):477-82. PubMed ID: 18705766
[TBL] [Abstract][Full Text] [Related]
35. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
36. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
37. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
40. Homozygous deletion of the FHIT gene, p21WAF1 protein expression and apoptosis in bilharzial bladder cancer.
Ghaleb KI; Alkaladi A
Pak J Biol Sci; 2011 Feb; 14(3):212-8. PubMed ID: 21870644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]